Back to Newsroom
Back to Newsroom

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DM, TLIS and BMBL

Tuesday, 25 January 2022 04:45 PM

The Klein Law Firm

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / January 25, 2022 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Desktop Metal, Inc. (NYSE:DM)
Class Period: March 15, 2021 - November 15, 2021
Lead Plaintiff Deadline: February 22, 2022

The complaint alleges that during the class period Desktop Metal, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) there were deficiencies in Desktop Metals' acquisition EnvisionTEC's manufacturing and product compliance practices and procedures; (2) the foregoing deficiencies presented a material risk to the commercialization of EnvisionTEC's products; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in DM: https://www.kleinstocklaw.com/pslra-1/desktop-metal-inc-loss-submission-form?id=22447&from=1

Talis Biomedical Corporation (NASDAQ:TLIS)
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Talis common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's February 2021 initial public offering.
Lead Plaintiff Deadline: March 8, 2022

According to the lawsuit, documents that the Company issued in connection with its IPO failed to disclose to investors: (1) that the comparator assay in the primary study lacked sufficient sensitivity to support Talis's Emergency Use Authorization application for Talis One COVID-19 test; (2) that, as a result, Talis was reasonably likely to experience delays in obtaining regulatory approval for the Talis One COVID-19 test; (3) that, as a result, the Company's commercialization timeline would be significantly delayed; and (4) that, as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in TLIS: https://www.kleinstocklaw.com/pslra-1/talis-biomedical-corporation-loss-submission-form?id=22447&from=1

Bumble Inc. (NASDAQ:BMBL)
This lawsuit is on behalf of all purchasers of the Class A common stock of Bumble directly in Bumble's secondary public stock offering which took place on or about September 10, 2021.
Lead Plaintiff Deadline: March 25, 2022

Throughout the class period, Bumble Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) Bumble's paying user growth trends had abruptly reversed in 3Q21 and the Company had actually lost tens of thousands of paying users during the quarter; (b) paying users had been more reluctant to sign up for the Bumble app during 3Q21 because of the recent price hike for paid services on the app; (c) a material number of paying users were leaving the Badoo app, a dating-focused social network, and/or could not make payments through the Badoo app due, in substantial part, to problems arising from the Company's transition of its payment platform; and (d) as a result of the foregoing, Bumble's business metrics and financial prospects were not as strong as the Registration Statement had represented.

Learn about your recoverable losses in BMBL: https://www.kleinstocklaw.com/pslra-1/bumble-inc-loss-submission-form?id=22447&from=1

The Klein Law Firm, Tuesday, January 25, 2022, Press release picture

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: